Term:Ollier disease
go back to main search page
Accession:DOID:4624 term browser browse the term
Definition:Benign growths of cartilage in the metaphyses of several bones.
Synonyms:exact_synonym: DYSCHONDROPLASIA;   Dyschondrodysplasia with Hemangiomas;   Dyschondroplasia and Cavernous Hemangioma;   ENCHONDROMATOSIS, MULTIPLE, OLLIER TYPE;   Enchondromatoses;   Enchondromatosis with Hemangiomata;   Enchondromatosis with Multiple Cavernous Hemangiomas;   Enchondromatosis with haemangiomata;   Enchondromatosis, Multiple;   Hemangiomata with Dyschondroplasia;   Hemangiomatosis Chondrodystrophica;   Kast Syndrome;   Kast's syndrome;   Multiple Angiomas and Endochondromas;   Multiple Enchondroma;   Multiple Enchondromas;   Multiple Enchondroses;   Multiple Enchondrosis;   Ollier's disease;   Olliers disease;   chondrodysplasia with hemangioma;   chondroplasia angiomatosis;   enchondromatosis;   osteochondromatosis
 primary_id: MESH:D004687
 alt_id: OMIM:166000;   RDO:0004480
 xref: GARD:7251;   ORDO:296
For additional species annotation, visit the Alliance of Genome Resources.

show annotations for term's descendants       view all columns           Sort by:
Ollier disease term browser
Symbol Object Name JBrowse Chr Start Stop Reference
G Idh1 isocitrate dehydrogenase (NADP(+)) 1, cytosolic JBrowse link 9 71,882,108 71,911,645 RGD:11554173
G Idh2 isocitrate dehydrogenase (NADP(+)) 2, mitochondrial JBrowse link 1 141,874,354 141,893,674 RGD:11554173
G Ptpn11 protein tyrosine phosphatase, non-receptor type 11 JBrowse link 12 40,895,515 40,955,999 RGD:11554173

Term paths to the root
Path 1
Term Annotations click to browse term
  disease 14875
    syndrome 4220
      Ollier disease 3
Path 2
Term Annotations click to browse term
  disease 14875
    disease of anatomical entity 14051
      musculoskeletal system disease 3984
        connective tissue disease 2572
          bone disease 2118
            bone development disease 891
              osteochondrodysplasia 403
                Ollier disease 3
paths to the root


RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.